Exit Options for John Hancock Bond and Corporate Finance Group: Hanover Communications In... - 28 Strategic Investors

View x

Capricorn Partners & Novax in funding round for plant-based protein company Prolupin

Capricorn Partners has joined a double-digit million growth financing round for plant-based protein firm Prolupin with an investment of EUR7 million, from its Capricorn Sustainable Chemistry Fund and Quest for Growth. The funding round was led by Capricorn Partners, an independent manager of private and quoted equity funds that invest in minority shareholding positions of companies with technology as competitive advantage, and Stockholm-based growth investor Novax powered by the Swedish Axel Johnson family. The round was initiated by existing investors Munich Venture Partners and eCapital Entrepreneurial Partners. Investment bank Bryan, Garnier & Co acted as financial advisor on the transaction.